IDH1 and astrocytoma (excluding glioblastoma): These tumors primarily include isocitrate dehydrogenase (IDH)-mutant astrocytomas and oligodendrogliomas with combined IDH mutation and 1p/19q co-deletion, which correspond to WHO grade 2 lesions within the spectrum of adult-type diffuse gliomas [1,2].